- Fraudulent Email Warning（27KB）
News Release
- May 22, 2026
- Notice of Personnel Changes（236KB）
- April 28, 2026
- Notice of Personnel Changes（182KB）
- April 3, 2026
- Notice of Personnel Changes（73KB）
IR News
- June 3, 2026
- Notice of the 73rd Annual General Meeting of Shareholders
- May 22, 2026
- Notice of Partial Amendments to the Articles of Incorporation
- May 12, 2026
- Consolidated Financial Results for the Fiscal Year Ended March 31, 2026 (Under Japanese GAAP) / Notice Regarding Recognition of Extraordinary Income (Subsidy Income) and Extraordinary Loss (Loss on Reduction of Non-Current Assets) / Notice Concerning Dividends from Surplus / IR Materials
Our Business
Meeting the needs of front line medical treatment with unique products and technologies
To meet the needs of the front line of medical treatment, NIPRO creates unique products at its four research and development sites while leveraging the technologies cultivated in its various businesses.
Mission, Vision, Value
We will work as a truly global comprehensive medical manufacturer with a willingness to consider patient and user viewpoints.
